High-definition transcranial grey noise stimulation (HD-tGNS) for the treatment of generalised anxiety disorder (GAD) in adults: A proof of concept study

Otago University0 个研究点目标入组 24 人开始时间: 2023年3月8日最近更新: 2023年3月20日

适应症

试验速览

暂无简介。

•Participants with a diagnosis of GAD will be eligible to participate. To be included in the study, participants must meet all of the following inclusion criteria:
•· Capable of understanding the study information and able to sign the informed consent form.
•· Age between 18 to 60 years on the day of the consent.

•Participants who meet any of the following conditions will be excluded:
•· History of neurological disorders
•· History of epilepsy or seizures
•· History of substance abuse (i.e., consuming more than 3 drinks on any day or more than 7 drinks per week for women, and more than 4 drinks on any day or more than 14 drinks per week for men).
•· Previous treatment with neuromodulation (e.g. Transcranial magnetic stimulation, electroconvulsive therapy, Neurofeedback, etc.)
•· Dyslipidaemia
•· Cognitive impairments (Dementia, Alzheimer’s disease, personality disorders, substance use disorders, certain medical conditions): A total score of 24 or below on Mini-Mental State Examination
•· History of uncontrolled/untreated hypertension
•· Presence of any pacemaker or defibrillator
•· Presence of any electronic implants or metal implant in the body (particularly head and neck)
•· Recent or current pregnancy
•Note ~ Participants will be permitted to continue their medications or ongoing psychotherapy for the duration of the trial, with the type and dosage of medication/therapy being recorded throughout the duration of the trial. However, participants with the intention of taking new medications/therapies in the next 2 months, will be excluded.

发起方

Otago University